Urinary Incontinence
📧 Sign up to get email alerts when something new happens for Urinary Incontinence.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2025-09-15EMA Authorised: Emselex (darifenacin hydrobromide) — pharmaand GmbH
The EMA authorised Emselex (darifenacin hydrobromide) for urinary incontinence due to urge and overactive bladder, with pharmaand GmbH as th…
-
FDA approval · 2025-08-21FDA Approved: TOLTERODINE TARTRATE — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approved a supplemental application for Tolterodine tartrate (tolterodine) submitted by Torrent Pharmaceuticals Limited, confirming …
-
EMA approval · 2025-07-08EMA Authorised: Obgemsa (vibegron) — Pierre Fabre Medicament
EMA has authorised Obgemsa (vibegron) for overactive bladder and urinary incontinence. The marketing authorization holder is Pierre Fabre Me…
-
FDA approval · 2025-06-17FDA Approved: TOLTERODINE TARTRATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for tolterodine tartrate submitted by Teva Pharmaceuticals USA, Inc.
-
EMA approval · 2025-04-08EMA Authorised: Kentera (previously Oxybutynin Nicobrand) (oxybutynin) — Teva B.V.
The European Medicines Agency authorised Kentera, a transdermal oxybutynin patch by Teva B.V., for urinary incontinence associated with urge…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-08-27FDA Approved: TOLTERODINE TARTRATE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved a generic tolterodine tartrate product (ANDA 216917) from Unichem Pharmaceuticals (USA), Inc. for the treatment of overacti…
-
FDA approval · 2024-02-20FDA Approved: SOLIFENACIN SUCCINATE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original application for solifenacin succinate (Macleods Pharmaceuticals Limited), a generic version for the treatment of o…
-
FDA approval · 2023-05-24FDA Approved: OXYBUTYNIN CHLORIDE EXTENDED RELEASE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for oxybutynin chloride extended-release by Rising Pharma Holdings, Inc., confirming the product and…
-
FDA approval · 2023-02-02FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Accord Healthcare, Inc.)
FDA approved a supplemental application for oxybutynin chloride from Accord Healthcare, Inc.
-
FDA approval · 2023-01-27FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Advagen Pharma Limited)
FDA approved a supplemental application for oxybutynin chloride from Advagen Pharma Limited.
-
FDA approval · 2022-10-07FDA Approved: TROSPIUM CHLORIDE — Supplemental Application (Granules Pharmaceuticals Inc.)
The FDA approved a supplemental application for trospium chloride from Granules Pharmaceuticals Inc. under ANDA213185. This confirms approva…
-
FDA approval · 2022-06-15FDA Approved: SOLIFENACIN SUCCINATE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' generic solifenacin succinate under an original ANDA submission, marking the approval of a generic vers…
-
FDA approval · 2022-02-16FDA Approved: TROSPIUM CHLORIDE — Original Application (Zameer Pharmaceuticals LLC)
FDA approved an original application for trospium chloride (generic) from Zameer Pharmaceuticals LLC, granting market authorization. It is i…
-
FDA approval · 2021-10-18FDA Approved: OXYBUTYNIN — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA has approved a supplemental application for Oxybutynin from Zydus Pharmaceuticals USA Inc., indicating an updated approval for the p…
-
FDA approval · 2021-08-02FDA Approved: TOLTERODINE TARTRATE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' Tolterodine tartrate as an original generic application.
-
FDA approval · 2020-10-27FDA Approved: OXYBUTYNIN CHLORIDE — Original Application (Advagen Pharma Limited)
FDA approved the generic oxybutynin chloride tablet from Advagen Pharma Limited under an Original Application.
-
FDA approval · 2020-05-26FDA Approved: VESICARE LS — Original Application (Astellas Pharma US, Inc.)
FDA approved Vesicare LS (solifenacin succinate) under an original NDA from Astellas Pharma US, Inc. for the treatment of overactive bladder…
-
FDA approval · 2020-05-19FDA Approved: TOLTERODINE TARTRATE — Original Application (Ajanta Pharma USA Inc.)
FDA approves Ajanta Pharma USA Inc.'s original application for tolterodine tartrate (generic tolterodine tartrate), a treatment for overacti…
-
FDA approval · 2020-04-06FDA Approved: OXYBUTYNIN CHLORIDE — Original Application (Leading Pharma, LLC)
FDA approved Leading Pharma, LLC's original Abbreviated New Drug Application for oxybutynin chloride, enabling a generic version of this ant…
-
FDA approval · 2020-03-13FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for oxybutynin chloride from Amneal Pharmaceuticals LLC, updating the approval of the existing gener…
-
FDA approval · 2020-03-09FDA Approved: TOLTERODINE TARTRATE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Tolterodine tartrate (Tolterodine) by Torrent Pharmaceuticals Limited.
-
FDA approval · 2020-02-28FDA Approved: OXYBUTYNIN CHLORIDE EXTENDED RELEASE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for an extended-release formulation of oxybutynin chloride, manufactured by Rising Pharma Holdings, …
-
FDA approval · 2020-02-28FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved a supplemental application for oxybutynin chloride from Ajanta Pharma USA Inc., authorizing the generic oxybutynin chloride pro…
-
FDA approval · 2019-09-09FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for oxybutynin chloride submitted by Chartwell RX, LLC. The approval confirms continuation of the ge…
-
FDA approval · 2019-08-19FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for oxybutynin chloride from Amneal Pharmaceuticals LLC.